The Power and Potential of Gene Tuning
By Fyodor Urnov,
Time
| 08. 12. 2024
After a lifetime in the field of epigenetics, and nearly 20 years after my colleagues and I coined the term “genome editing,” I will be the first to admit that describing the “epigenome”—a marvelous biological process that guides what our genes do—takes a bit of explaining. I find that thinking about the genome and epigenome in terms of music and sound-mixing can be helpful here.
We experience all sorts of music as we go through life, from Bach and Brahms to Laufey and Lizzo. It is remarkable that you can do so many different things musically from just a few basic components. You have a defined set of notes, which can be played separately or together in an enormous number of combinations and time signatures. Those notes can be played at different volumes—some louder, some softer. And finally, those same notes can have different textures. The note of A as played on a violin sounds very different when played by a distorted, death-metal guitar. Each has the same number of vibrations per unit time, but...
Related Articles
By Sarojini Nadimpally and Gargi Mishra, The Wire | 12.15.2024
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind...
Image by Mohamed Hassan from Pixabay
It is hard to make predictions, especially about the future, as Yogi Berra, Niels Bohr, and other luminaries have remarked. But there are already signs that the incoming Trump administration may have some difficulty establishing consistent policies about controversial issues concerning human reproduction.
On the one hand, consider “the conservative blueprint for a second Trump administration.”
The notorious Project 2025’s Mandate for Leadership seeks to delete terms such as “reproductive rights” from “every federal...
By Susan Dominus, The New York Times | 11.30.2024
In the days after Daphna Cardinale delivered her second child, she experienced a rare sense of calm and wonder. The feeling was a relief after so much worrying: She and her husband, Alexander, had tried for three years to conceive...
By Christy Santhosh, Reuters | 11.27.2024
Nov 27 (Reuters) - The U.S. Food and Drug Administration is weighing the need for regulatory action on bluebird bio's (BLUE.O), opens new tab gene therapy for a rare neurological disorder, it said on Wednesday, as the agency probes additional...